Quotient Sciences Acquires Arcinova

Read the press release here

Arcinova Q3 Newsletter 2016

We are proud to present our first quarterly newsletter, with important updates including the progression of our API development capabilities and the addition of GC-MS to broaden the scope of our offerings to our customers. 

Click to view newsletter






Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.